Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 330.85 INR 0.33% Market Closed
Market Cap: 30.5B INR
Have any thoughts about
Indoco Remedies Ltd?
Write Note

Indoco Remedies Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Indoco Remedies Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Indoco Remedies Ltd
NSE:INDOCO
Cash & Cash Equivalents
â‚ą141.3m
CAGR 3-Years
17%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash & Cash Equivalents
â‚ą11.3B
CAGR 3-Years
4%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash & Cash Equivalents
â‚ą9.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
16%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash & Cash Equivalents
â‚ą90.2B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash & Cash Equivalents
â‚ą11.5B
CAGR 3-Years
49%
CAGR 5-Years
14%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Cash & Cash Equivalents
â‚ą1.2B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Indoco Remedies Ltd
Glance View

Market Cap
30.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
409.51 INR
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Indoco Remedies Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
141.3m INR

Based on the financial report for Mar 31, 2024, Indoco Remedies Ltd's Cash & Cash Equivalents amounts to 141.3m INR.

What is Indoco Remedies Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
4%

The average annual Cash & Cash Equivalents growth rates for Indoco Remedies Ltd have been 17% over the past three years , 4% over the past five years .

Back to Top